Allspring Global Investments Holdings, LLC I Teos Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$10.33 - $18.09 $61,887 - $108,377	-5,991 Reduced 61.34%	3,776 $56,000
Q1 2024 Apr 18, 2024	SELL	$9.89 - $13.64 $85,499 - $117,917	-8,645 Reduced 46.95%	9,767 $133,000
Q4 2023 Jan 25, 2024	BUY	$8.57 - $11.06 $154,028 - $198,781	17,973 Added 4094.08%	18,412 $201,000
Q3 2023 Oct 27, 2023	BUY	$10.95 - $14.6 $4,807 - $6,409	439 New	439 $4,000
Q2 2023 Jul 18, 2023	SELL	$12.93 - $18.05 $33,100 - $46,208	-2,560 Reduced 14.46%	15,150 $200,000
Q1 2023 Apr 13, 2023	SELL	$13.02 - $22.62 $1.18 Million - $2.06 Million	-90,960 Reduced 83.7%	17,710 $241,000
Q4 2022 Jan 23, 2023	BUY	$17.77 - $21.6 $703,141 - $854,690	39,569 Added 57.26%	108,670 $0
Q3 2022 Oct 26, 2022	SELL	$18.6 - $27.25 $3.78 Million - $5.54 Million	-203,237 Reduced 74.63%	69,101 $1.32 Million
Q2 2022 Jul 25, 2022	BUY	$16.57 - $35.1 $1.63 Million - $3.46 Million	98,451 Added 56.62%	272,338 $5.61 Million
Q1 2022 May 02, 2022	BUY	$31.92 - $47.45 $3.75 Million - $5.57 Million	117,384 Added 207.75%	173,887 $0
Q4 2021 Jan 28, 2022	BUY	$26.23 - $47.86 $1.48 Million - $2.7 Million	56,503 New	56,503 $2.63 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

Black Rock Inc. New York, NY

3.73M
Shares

$27.1 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

3.18M
Shares

$23.1 Million
0.45% of portfolio
Boxer Capital, LLC San Diego, CA

2.95M
Shares

$21.4 Million
1.6% of portfolio
Mpm Asset Management LLC Cambridge, MA

2.74M
Shares

$19.9 Million
19.24% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$17.5 Million
2.09% of portfolio

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $258M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account